It is also possible, with the experimental design that we are modeling, that after drug administration, more free human IL-6 in the tumor environment will be available for binding to murine IL-6R, leading to angiogenesis and other events that can provide better conditions for cell survival thereby impacting δD. This evidence concerns the gene IL6 and neoplasm.